Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
Keyword(s):
The Breelib™ nebulizer was designed to reduce iloprost inhalation times for patients with pulmonary arterial hypertension (PAH). In 30 patients with PAH, rapid inhalation of iloprost 2.5 µg using Breelib™ caused significant improvements in invasively measured afterload and cardiac index but not echocardiographic right ventricular strain during 30 min post-inhalation.
2016 ◽
Vol 33
(1)
◽
pp. 39-46
◽
2019 ◽
Vol 73
(9)
◽
pp. 1899
2018 ◽
Vol 197
(3)
◽
pp. 388-391
◽
2004 ◽
Vol 3
(1)
◽
pp. 14-15